LRRK2 mutations and Parkinson's disease in Sardinia-A Mediterranean genetic isolate

Parkinsonism and Related Disorders

Volumn 13, Issue 1, 2007, Pages 17-21

  Cossu, Giovanni ^a   van Doeselaar, Marina ^b   Deriu, Marcello ^a   Melis, Maurizio ^a   Molari, Andrea ^a   Di Fonzo, Alessio ^b,c,d   Oostra, Ben A ^b   Bonifati, Vincenzo ^b  

^a San Michele Hospital   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MILAN   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Genetic isolates; LRRK2; Mutation; Parkinson's disease; Sardinia

Indexed keywords

ARGININE; GLYCINE; LEUCINE RICH REPEAT KINASE 2; SERINE;

AGED; ARTICLE; CASE REPORT; FAMILY HISTORY; GENE; GENE ISOLATION; GENE MUTATION; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; LRRK2 GENE; MALE; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; SARDINIA; SOUTHERN EUROPE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PENETRANCE; PROTEIN-SERINE-THREONINE KINASES;

EID: 33846526175     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2006.06.010     Document Type: Article

References (37)

1. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., et al. Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron 44 (2004) 601-607
2. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 (2004) 595-600
3. Bonifati V. The LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics. Eur J Hum Genet 2006; Epub ahead of print, July 12. doi:10.1038/sj.ejhg.5201695.
4. Mata I.F., Taylor J.P., Kachergus J., Hulihan M., Huerta C., Lahoz C., et al. LRRK2 R1441G in Spanish patients with Parkinson's disease. Neurosci Lett 382 (2005) 309-311
5. Bras J.M., Guerreiro R.J., Ribeiro M.H., Januario C., Morgadinho A., Oliveira C.R., et al. G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort. Mov Disord 20 (2005) 1653-1655
6. Gaig C., Ezquerra M., Marti M.J., Munoz E., Valldeoriola F., and Tolosa E. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. Arch Neurol 63 (2006) 377-382
7. Infante J., Rodriguez E., Combarros O., Mateo I., Fontalba A., Pascual J., et al. LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease. Neurosci Lett 395 (2005) 224-226
8. Lesage S., Durr A., Tazir M., Lohmann E., Leutenegger A.L., Janin S., et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 354 (2006) 422-423
9. Ozelius L.J., Senthil G., Saunders-Pullman R., Ohmann E., Deligtisch A., Tagliati M., et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 354 (2006) 424-425
10. Goldwurm S., Di Fonzo A., Simons E.J., Rohe C.F., Zini M., Canesi M., et al. The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor. J Med Genet 42 (2005) e65
11. Goldwurm S, Zini M, Di Fonzo A, De Gaspari D, Siri C, Simons EJ, et al. LRRK2 G2019S mutation and Parkinson's disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample. Parkinsonism Relat Disord 2006; Epub ahead of print, June 2. doi:10.1016/j.parkreldis.2006.04.001.
12. Gilks W.P., Abou-Sleiman P.M., Gandhi S., Jain S., Singleton A., Lees A.J., et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 365 (2005) 415-416
13. Bialecka M., Hui S., Klodowska-Duda G., Opala G., Tan E.K., and Drozdzik M. Analysis of LRRK2 G2019S and I2020T mutations in Parkinson's disease. Neurosci Lett 390 (2005) 1-3
14. Lu C.S., Simons E.J., Wu-Chou Y.H., Di Fonzo A., Chang H.C., Chen R.S., et al. The LRRK2 I2012T, G2019S, and I2020T mutations are rare in Taiwanese patients with sporadic Parkinson's disease. Parkinsonism Relat Disord 11 (2005) 521-522
15. Tan E.K., Shen H., Tan L.C., Farrer M., Yew K., Chua E., et al. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Neurosci Lett 384 (2005) 327-329
16. Semino O., Passarino G., Oefner P.J., Lin A.A., Arbuzova S., Beckman L.E., et al. The genetic legacy of Paleolithic Homo sapiens sapiens in extant Europeans: a Y chromosome perspective. Science 290 (2000) 1155-1159
17. Francalacci P., Morelli L., Underhill P.A., Lillie A.S., Passarino G., Useli A., et al. Peopling of three Mediterranean islands (Corsica, Sardinia, and Sicily) inferred by Y-chromosome biallelic variability. Am J Phys Anthropol 121 (2003) 270-279
18. Zavattari P., Deidda E., Whalen M., Lampis R., Mulargia A., Loddo M., et al. Major factors influencing linkage disequilibrium by analysis of different chromosome regions in distinct populations: demography, chromosome recombination frequency and selection. Hum Mol Genet 9 (2000) 2947-2957
19. Tenesa A., Wright A.F., Knott S.A., Carothers A.D., Hayward C., Angius A., et al. Extent of linkage disequilibrium in a Sardinian sub-isolate: sampling and methodological considerations. Hum Mol Genet 13 (2004) 25-33
20. Service S., Deyoung J., Karayiorgou M., Roos J.L., Pretorious H., Bedoya G., et al. Magnitude and distribution of linkage disequilibrium in population isolates and implications for genome-wide association studies. Nat Genet 38 (2006) 556-560
21. Grimaldi M.C., Crouau-Roy B., Amoros J.P., Cambon-Thomsen A., Carcassi C., Orru S., et al. West Mediterranean islands (Corsica, Balearic islands, Sardinia) and the Basque population: contribution of HLA class I molecular markers to their evolutionary history. Tissue Antigens 58 (2001) 281-292
22. Wszolek Z.K., Pfeiffer R.F., Tsuboi Y., Uitti R.J., McComb R.D., Stoessl A.J., et al. Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 62 (2004) 1619-1622
23. Di Fonzo A., Tassorelli C., De Mari M., Chien H.F., Ferreira J., Rohe C.F., et al. Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet 14 (2006) 322-331
24. Mata I.F., Kachergus J.M., Taylor J.P., Lincoln S., Aasly J., Lynch T., et al. Lrrk2 pathogenic substitutions in Parkinson's disease. Neurogenetics 6 (2005) 171-177
25. Zabetian C.P., Samii A., Mosley A.D., Roberts J.W., Leis B.C., Yearout D., et al. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology 65 (2005) 741-744
26. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
27. Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. Recent Developments in Parkinson's Disease. New York: Macmillan; 1987: 153-63.
28. Di Fonzo A., Rohe C.F., Ferreira J., Chien H.F., Vacca L., Stocchi F., et al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365 (2005) 412-415
29. Kachergus J., Mata I.F., Hulihan M., Taylor J.P., Lincoln S., Aasly J., et al. Identification of a Novel LRRK2 mutation linked to autosomal dominant Parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 76 (2005) 672-680
30. Lesage S., Leutenegger A.-L., Ibanez P., Janin S., Lohmann E., Durr A., et al. LRRK2 haplotype analyses in European and North African families with Parkinson's disease: a common founder for the G2019S mutation dating from the 13th century. Am J Hum Genet 77 (2005) 330-332
31. Funayama M., Hasegawa K., Kowa H., Saito M., Tsuji S., and Obata F. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 51 (2002) 296-301
32. Zimprich A., Muller-Myhsok B., Farrer M., Leitner P., Sharma M., Hulihan M., et al. The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet 74 (2004) 11-19
33. Kay D.M., Kramer P., Higgins D., Zabetian C.P., and Payami H. Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation. Mov Disord 20 (2005) 1077-1078
34. Adams J.R., van Netten H., Schulzer M., Mak E., McKenzie J., Strongosky A., et al. PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation. Brain 128 (2005) 2777-2785
35. Rosati G., Granieri E., Pinna L., Aiello I., Tola R., De Bastiani P., et al. The risk of Parkinson disease in Mediterranean people. Neurology 30 (1980) 250-255
36. Heutink P., and Oostra B.A. Gene finding in genetically isolated populations. Hum Mol Genet 11 (2002) 2507-2515
37. Varilo T., and Peltonen L. Isolates and their potential use in complex gene mapping efforts. Curr Opin Genet Dev 14 (2004) 316-323